Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression profiling of Ewing sarcoma samples

ABSTRACT: Expression profiling of Ewing sarcoma samples in the frame of the CIT program from the french Ligue Nationale Contre le Cancer (http://cit.ligue-cancer.net). Ewing sarcoma a rare pediatric tumor characterized by EWSR1-ETS fusions, is predominantly observed in populations of European ancestry. A genome-wide association study of at least 401 French ES patients compared to either 684 French or 3668 US self-described Caucasian controls consistently revealed candidate loci at chromosomes 1 and 10 (p<10-6). These loci were further replicated in two independent sets of cases and controls. Joint analysis identified rs9430161 (p=1.4x10-20; OR=2.2, CI99=1.8-2.7) 25kb upstream to TARDBP (1p36.22) and rs224278 (p=4.0x10-17 OR=1.7, CI99=1.4-1.9) 5kb upstream to EGR2 (10q21). The frequency of the major risk haplotypes in the European population were observed to be less prevalent in the African population, suggesting that variants at these loci could contribute to the differences in ES incidence observed between continents. TARDBP shares structural similarities with EWSR1 and FUS (TLS) EGR2 is an EWSR1-ETS target gene. Variants at both loci were associated with expression levels of TARDBP, ADO and EGR2. 117 Ewing sarcoma samples were profiled using affymetrix hgu133Plus2 arrays.

ORGANISM(S): Homo sapiens

SUBMITTER: Franck Tirode 

PROVIDER: E-GEOD-34620 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

Ewing sarcoma, a pediatric tumor characterized by EWSR1-ETS fusions, is predominantly observed in populations of European ancestry. We performed a genome-wide association study (GWAS) of 401 French individuals with Ewing sarcoma, 684 unaffected French individuals and 3,668 unaffected individuals of European descent and living in the United States. We identified candidate risk loci at 1p36.22, 10q21 and 15q15. We replicated these loci in two independent sets of cases and controls. Joint analysis  ...[more]

Similar Datasets

Unknown Expression profiling of Ewing sarcoma samples
2012-02-11 | GSE34620 | GEO
Transcriptomics Gene expression profiling of human Ewing sarcoma cells after knockdown of EGR2 or EWSR1-FLI1.
2015-07-26 | E-GEOD-62090 | biostudies-arrayexpress
Unknown Gene expression profiling of human Ewing sarcoma cells after knockdown of EGR2 or EWSR1-FLI1.
2015-07-26 | GSE62090 | GEO
Transcriptomics Expression data from Ewing's sarcoma tumor samples
2012-06-11 | E-GEOD-37371 | biostudies-arrayexpress
Unknown Expression data from Ewing's sarcoma tumor samples
2012-06-12 | GSE37371 | GEO
Unknown The Ewing sarcoma cell line atlas (ESCLA) - The relevance of the transcription factors GATA2 and E2F2 in a Ewing sarcoma cell line model
2022-08-26 | GSE212063 | GEO
Unknown The Ewing Sarcoma Cell Line Atlas (ESCLA) - methylation profiling of 18 Ewing sarcoma cell lines in EWSR1-ETS-high versus -low condition
2021-06-09 | GSE176334 | GEO
Unknown The Ewing Sarcoma Cell Line Atlas - Systematic analysis of genome-wide EWSR1-ETS binding and histone marks in 18 Ewing sarcoma cell lines by ChIP-seq
2021-06-09 | GSE176400 | GEO
Unknown The Ewing Sarcoma Cell Line Atlas (ESCLA) - expression profiling of 18 Ewing sarcoma cell lines in EWSR1-ETS-high versus -low condition
2021-06-09 | GSE176190 | GEO
Transcriptomics Pharmacologic Inhibition of Epigenetic Modification Reveals Targets of Aberrant Promoter Methylation in Ewing Sarcoma
2014-03-05 | E-GEOD-44934 | biostudies-arrayexpress